Could COVID shots boost cancer treatment? researchers investigate
NCT ID NCT07341321
Summary
This study looks back at medical records to see if getting a COVID mRNA vaccine shortly before starting immunotherapy helps people with liver cancer respond better to treatment. Researchers will analyze data from about 200 patients in Austria who received both the vaccine and cancer drugs called immune checkpoint inhibitors. The goal is to understand if timing the vaccine before immunotherapy improves treatment outcomes and survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinikum Wels-Grieskirchen
Wels, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Krankenhaus der Barmherzigen Brüder St Veit an der Glan
Sankt Veit an der Glan, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical University of Graz
Graz, 8010, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ordensklinikum Linz
Linz, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital St. Pölten
Sankt Pölten, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.